Sort
25,944 grants matching “neurodegeneration”
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease
$497,200Jianhua Zhou · Inflamed, Inc. · R43 · FY2023 · AG
Function of TMEM106B in neurodegeneration
$497,123Fenghua Hu · Cornell University · R01 · FY2022 · NS
Function of TMEM106B in neurodegeneration
$497,123Fenghua Hu · Cornell University · R01 · FY2021 · NS
Function of TMEM106B in Neurodegeneration
$497,123Fenghua Hu · Cornell University · R01 · FY2025 · NS
Function of TMEM106B in Neurodegeneration
$497,123Fenghua Hu · Cornell University · R01 · FY2024 · NS
Function of TMEM106B in Neurodegeneration
$497,123Fenghua Hu · Cornell University · R01 · FY2023 · NS
Evaluating a novel, orally-active TREM2-targeting drug in AD
$497,059Nora Gray · Oregon Health & Science University · R01 · FY2025 · AG
Role of glial sphingolipid ceramide in aging and Alzheimer's disease
$496,911Jianrong Li · Texas A&M Agrilife Research · R01 · FY2025 · AG
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in Drosophila
$496,909Pankaj Kapahi · Buck Institute For Research On Aging · R01 · FY2011 · AG
Cytochrome c Oxidase Assembly in Health and Disease
$496,823Antoni Barrientos · University Of Miami School Of Medicine · R01 · FY2014 · GM
A Comprehensive Database Resource on Protein Catabolism
$496,710Cognia Corporation · R44 · FY2003 · GM
Aging and Dementia in Down Syndrome: Connectivity, Inflammation, and Cerebrovascular Contributions
$496,429Elizabeth Head · University Of Kentucky · R01 · FY2017 · HD
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
$496,400Jeffrey Scott Wefel · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · NR
Deep gray matter iron and disease progression in multiple sclerosis
$496,397Ferdinand Schweser · State University Of New York At Buffalo · R01 · FY2021 · NS
Using Multiplex Families to map Genes that Modify Susceptibility and Age at Onset
$496,296Cyrus P Zabetian · University Of Washington · R01 · FY2012 · NS
Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Exercise and/or Cognitive Training in Amnestic Mild Cognitive Impairment
$496,114Danni Li · University Of Minnesota · R01 · FY2019 · AG
Amyloid, white matter hyperintensities & outcomes of late-life depression
$495,855Meryl A Butters · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · MH
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease
$495,578Joshua M Shulman · Baylor College Of Medicine · R01 · FY2018 · AG
Project 2: Molecular aspects of endocrine and metabolic dysregulation in neurodegeneration
$495,542Steven W Barger · Univ Of Arkansas For Med Scis · P01 · FY2016 · AG
RNA binding proteins as novel targets in Alzheimer's disease
$495,464Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2015 · AG
Replication mechanism of human prions
$495,208Jiri G. Safar · Case Western Reserve University · R01 · FY2014 · NS
Ataxin-7 oligonucleotide knock-down to treat SCA7 retinal and cerebellar disease
$495,152Albert R La Spada · University Of California, San Diego · R01 · FY2016 · EY
Ataxin-7 oligonucleotide knock-down to treat SCA7 retinal and cerebellar disease
$495,140Albert R La Spada · University Of California, San Diego · R01 · FY2014 · EY
Multidisciplinary Research Fellowship in Alzheimer's disease and Related Dementias
$495,102Howard J Rosen · University Of California, San Francisco · T32 · FY2020 · AG
Neuroimaging and Molecular Markers of AD and Neurodegenerative Disease after Concussion
$495,020Jasmeet Pannu Hayes · Ohio State University · R01 · FY2021 · AG